Shigella4V Tetravalent Bioconjugate Vaccine — Vax-Before-Travel

Shigella4V Tetravalent Bioconjugate Vaccine

Fact checked by Robert Carlson, MD

Nov 23

3 min read

A Shift in Shigellosis Cases Highlights Vaccine Need

Shigellosis vaccine Candidate Granted FDA Fast Track designation

vaccine

Fact checked by Robert Carlson, MD

Nov 13

4 min read

Shigella Vaccine May Soon Stop Diarrheal Disease Outbreaks

Tetravalent Shigella Vaccine Candidate Launches Phase 2b Human Challenge Study

Fact checked by Robert Carlson, MD

Oct 16

3 min read

Shigella Vaccine Candidate Awarded U.S. FDA Fast Track Designation

Valneva SE will be responsible for the first shigella vaccine worldwide commercialization

vaccine

Fact checked by Robert Carlson, MD

Oct 14

3 min read

Shigella Vaccine Candidate Advancing in Clinical Trials

Shigella4V tetravalent bioconjugate vaccine candidate prevents shigellosis infections